During the consultation on the draft guidance Janssen, the manufacturer of the drug, submitted further information for the committee to consider.
This included a revised patient access scheme which involves providing the drug to the NHS at a discounted price, further information on which patients would benefit most and clarification on how many patients could receive the drug.
These factors enabled the committee to revise its preliminary recommendation and now recommend the drug for use on the NHS.
More top news
Five Palestinians were reportedly shot dead by Israeli soldiers after a fresh spate of clashes broke out in the conflict-ridden region.
This weekend: Patchy rain in the northwest, dry and bright elsewhere.
Former ITN newscaster Gordon Honeycombe has died aged 79 in Australia, his family has said.